Patients with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, live an average of only three years after ...
An international research group recently demonstrated that the antibody NG101 promotes the regeneration of damaged spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results